Acetyl Cysteine + Taurine Tablets bulk supplier for pharma manufacturers

Acetyl Cysteine + Taurine Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Acetylcysteine: 150 mg Taurine: 500 mg

Reference Brands: Nefrosol-T, Nacrenef-T, and Renotyl

Category: Nephrology

Acetyl Cysteine + Taurine Tablets is available in Tablet and strengths such as Acetylcysteine: 150 mg Taurine: 500 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Acetyl Cysteine + Taurine Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Acetyl Cysteine + Taurine Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description:

Acetylcysteine + Taurine Tablets are a powerful antioxidant combination often used in nephrology, particularly for managing diabetic nephropathy and chronic kidney disease. Acetylcysteine helps reduce oxidative stress and improves kidney function, while Taurine supports cellular health and detoxification. Though widely available in countries like India under brands such as Nefrosol-T and Renotyl, this specific combination is not yet approved as a standard treatment in the US or EU. However, both ingredients are available individually as supplements. This formulation is gaining attention for its potential kidney-protective effects and may offer supportive therapy for individuals at risk of kidney damage.

Frequently Asked Questions

Yes, Acetyl Cysteine + Taurine Tablets is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Acetyl Cysteine + Taurine Tablets is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Calcitriol

Strength: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL

Form: Capsules & Injection

Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)

View Details
Paricalcitol Generics

Strength: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL

Form: Capsules and Injection

Reference Brands: Zemplar®(US &EU)

View Details
Calcifediol

Strength: 30 mcg

Form: ER Oral Capsule

Reference Brands: Rayaldee®(US)

View Details
Methoxy Polyethylene Glycol-Epoetin Beta Generics

Strength: 25–250 mcg

Form: Solution for Injection

Reference Brands: Mircera® (US &EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.